Quantcast

Tag Archives: biopharmaceutical

UK drug company to put US headquarters in Rockville, create 170 jobs

(kwanchaidp / Depositphotos.com)

Autolus, a biopharmaceutical company based in the United Kingdom, plans to create a new U.S. headquarters in Rockville, creating about 170 jobs by 2021. The company discovers and develops cancer treatments using T-cell programming and manufacturing. “Autolus is delighted to ...

Read More »

Md. lures Vitreon to Baltimore; firm plans to create 200 jobs

(File photo)

Medicinal botanical company Vitreon America announced Monday it plans to move its corporate headquarters to Baltimore from Virginia, creating 200 full-time jobs over the next five years. In addition to its new headquarters on Wicomico Street, the company also indicated it ...

Read More »

GlycoMimetics-Pfizer accord pays off

GlycoMimetics Inc., of Gaithersburg, a biopharmaceutical company focused on discovering and developing drugs for human wound healing and tissue repair, said it has received a $15 million payment from Pfizer Inc., under a collaborative agreement between the two companies for the development of rivipansel, a treatment for painful episodic flare-ups of sickle cell disease.

Read More »

Baltimore-based Cerecor obtains depression drug rights

Cerecor Inc., of Baltimore, a biopharmaceutical company focused on developing and commercializing prescription drugs involving the human nervous system, said it has acquired from Merck & Co. the exclusive, worldwide rights to a drug called MK-0657, which it said has the potential to treat depression. Merck originally developed MK-0657 for treatment of Parkinson’s disease.

Read More »

MedImmune expands Frederick plant

FREDERICK — The biopharmaceutical company MedImmune is expanding its Frederick manufacturing plant. Frederick city and county officials joined the company in celebrating the official opening Friday of a 337,000-square-foot addition. The new space expands production capacity for products including Synagis, ...

Read More »

Rockville-based Vanda Pharmaceuticals partners with Mexican firm

Vanda Pharmaceuticals Inc. of Rockville, a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced an exclusive licensing agreement with Probiomed S.A. de C.V., a wholly owned pharmaceutical operating unit of Proquifin S.A. ...

Read More »

Ex-CEO of Lux Biosciences named COO at Micromet

BETHESDA — Cancer drug developer Micromet Inc. on Tuesday named Ulrich Grau, a biopharmaceutical industry veteran, as its executive vice president and chief operating officer, effective immediately. Grau has more than 30 years of experience in operations and research and ...

Read More »